1. miR-378-3p Knockdown Recapitulates Many of the Features of Myelodysplastic Syndromes
- Author
-
Begum Utz, Sabin A. Nettles, Natalia Wojciechowska, Claudio A. Mosse, Maria O'Neill, Jonathan Scher, Joshua Keegan, Emma Y. Gagne, Yan Guo, Lia Barrow, Annette S. Kim, Miao Lin, Amma Bosompem, Catherine E. Alford, Dahai Wang, James A. Lederer, and Yahya Daneshbod
- Subjects
Adult ,Male ,Myeloid ,HL-60 Cells ,Biology ,Pathology and Forensic Medicine ,hemic and lymphatic diseases ,microRNA ,medicine ,Humans ,Epigenetics ,Aged ,Aged, 80 and over ,Gene knockdown ,Myelodysplastic syndromes ,Hematopoietic stem cell ,Regular Article ,Middle Aged ,medicine.disease ,Phenotype ,MicroRNAs ,Haematopoiesis ,medicine.anatomical_structure ,Gene Knockdown Techniques ,Myelodysplastic Syndromes ,Cancer research ,Female - Abstract
Myelodysplastic syndromes (MDS) are clonal neoplasms of the hematopoietic stem cell that result in aberrant differentiation of hematopoietic lineages caused by a wide range of underlying genetic, epigenetic, and other causes. Despite the myriad origins, a recognizable MDS phenotype has been associated with miRNA aberrant expression. A model of aberrant myeloid maturation that mimics MDS was generated using a stable knockdown of miR-378-3p. This model exhibited a transcriptional profile indicating aberrant maturation and function, immunophenotypic and morphologic dysplasia, and aberrant growth that characterizes MDS. Moreover, aberrant signal transduction in response to stimulation specific to the stage of myeloid maturation as indicated by CyTOF mass cytometry was similar to that found in samples from patients with MDS. The aberrant signaling, immunophenotypic changes, cellular growth, and colony formation ability seen in this myeloid model could be reversed with azacytidine, albeit without significant improvement of neutrophil function.
- Published
- 2021
- Full Text
- View/download PDF